ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex: BTIM) Chief Executive Officer Michael West, Ph.D. will give two presentations at the Stem Cells USA & Regenerative Medicine Congress 2009 to be held at The Westin Washington DC City Center Hotel in Washington, DC from November 16-18, 2009. On Tuesday, November 17, Dr. West will discuss applications of stem cell technology for diseases of the skin and bone. Dr. West will provide an update on BioTime’s ACTCellerate™ technology platform in cartilage biology and will disclose new data from the Company’s fate space screen. Then on Wednesday, November 18, Dr. West will give a presentation during a panel session discussing business models for regenerative medicine. Both presentations will be made available on the Company’s website at www.biotimeinc.com.
